APVO - Aptevo Therapeutics GAAP EPS of -$6.07 beats by $0.07 revenue of $12.29M beats by $0.26M
Aptevo Therapeutics press release (NASDAQ:APVO): FY GAAP EPS of -$6.07 beats by $0.07. Revenue of $12.29M (+185.2% Y/Y) beats by $0.26M. Cash and cash equivalents as of December 31, 2021 totaling $46.3 million, including restricted cash of $1.3 million Shares +7.25% PM.
For further details see:
Aptevo Therapeutics GAAP EPS of -$6.07 beats by $0.07, revenue of $12.29M beats by $0.26M